Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
about
Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growthProtein kinase cascades in the regulation of cardiac hypertrophyPLIP, a novel splice variant of Tip60, interacts with group IV cytosolic phospholipase A(2), induces apoptosis, and potentiates prostaglandin productionHistone deacetylase signaling in cardioprotectionmiR-9 and NFATc3 regulate myocardin in cardiac hypertrophyMechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3βMyostatin regulates cardiomyocyte growth through modulation of Akt signalingThe GSK-3 family as therapeutic target for myocardial diseasesMolecular basis of physiological heart growth: fundamental concepts and new playersThe cell biology of disease: cellular mechanisms of cardiomyopathy.Cardiac Troponin and Tropomyosin: Structural and Cellular Perspectives to Unveil the Hypertrophic Cardiomyopathy PhenotypeStabilization of beta-catenin by a Wnt-independent mechanism regulates cardiomyocyte growthMood stabilizers, glycogen synthase kinase-3beta and cell survivalThe beta-catenin/T-cell factor/lymphocyte enhancer factor signaling pathway is required for normal and stress-induced cardiac hypertrophyProapoptotic stimuli induce nuclear accumulation of glycogen synthase kinase-3 betaOverexpression of TEAD-1 in transgenic mouse striated muscles produces a slower skeletal muscle contractile phenotypeActivated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivoThe pro-hypertrophic basic helix-loop-helix protein p8 is degraded by the ubiquitin/proteasome system in a protein kinase B/Akt- and glycogen synthase kinase-3-dependent manner, whereas endothelin induction of p8 mRNA and renal mesangial cell hypertAngiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophyInhibition of glycogen synthase kinase 3[beta] activity with lithium in vitro attenuates sepsis-induced changes in muscle protein turnoverGlycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo.Deletion of CXCR4 in cardiomyocytes exacerbates cardiac dysfunction following isoproterenol administrationToward transcriptional therapies for the failing heart: chemical screens to modulate genesDirect and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.TEAD-1 overexpression in the mouse heart promotes an age-dependent heart dysfunction.Regulation of calcineurin through transcriptional induction of the calcineurin A beta promoter in vitro and in vivo.Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivoInfluence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheepMotility, survival, and proliferation.Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.β-Adrenergic receptor-PI3K signaling crosstalk in mouse heart: elucidation of immediate downstream signaling cascades.Mouse DTEF-1 (ETFR-1, TEF-5) is a transcriptional activator in alpha 1-adrenergic agonist-stimulated cardiac myocytes.Myocardial stress remodelling after regional infarction is independent of glycogen synthase kinase-3 inactivation.Soy diet worsens heart disease in mice.Akt/protein kinase B promotes organ growth in transgenic mice.Wnt11 promotes cardiomyocyte development by caspase-mediated suppression of canonical Wnt signalsThe FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling.Glucose phosphorylation is required for insulin-dependent mTOR signalling in the heart.Calcineurin and cardiac hypertrophy: where have we been? Where are we going?
P2860
Q24309615-AFE553EF-2E33-413F-B865-FBC42B1AB972Q24518494-28158C69-1356-472B-B240-297CE8AEE14DQ24550934-9AD7D123-99E3-4EE0-8465-7B89085170BFQ24568237-AF2AFAE4-6055-4596-977F-E30FB112978AQ24598242-4526EE40-3DA1-4A59-835F-C637FF2B1847Q24610983-15988705-C0C4-4D79-9FC1-B07525AB2159Q24614013-84C4C7EA-70FC-48AE-8986-A4C3144AC5A9Q26861134-14B99B9D-E735-4FC1-AE87-3B3607258D46Q27006868-0FD57A4D-9346-48AE-B262-316FB60668B7Q27686758-61E7784A-5626-4DA5-BF8D-47DB36E40870Q28066435-80376677-DD90-459D-935F-1FC0D007DF4AQ28187862-B6C8E985-6599-4574-A9E6-2788C7B0DAAEQ28216404-680CBA6D-CE34-44CF-A92A-9ED853FEFE7AQ28243220-4599327F-B63E-478B-A93C-D1D8AC07612CQ28345704-DF1B24BD-BB9F-4DC9-8587-DEDC40DF5108Q28507339-B907B4FC-1782-4F13-8D0A-EF354FC9CC86Q28511213-567ECF9B-5DC6-43EF-A07C-BF68EFF902CFQ28564994-D4D83082-914F-452A-8D79-637BEA1C7113Q28566875-B5239CDB-A5F3-4380-BDF6-47D04BF1FC93Q28576092-5DF8CA76-94EA-4CE4-BB21-C06F7412315CQ33293406-24440835-C587-4A92-842D-E326A134312DQ33590761-7B99E2E4-E60E-420A-AA4F-9BE11F2538B2Q33683749-180C591F-01FB-46CC-8DE2-7C99363BD768Q33713890-1C5E6C96-00A3-473C-9438-0B316A4AAF6CQ33810072-A4A792A4-DD46-4FA2-9685-D0E1259FEE3AQ33925316-3300F547-B548-4178-8FA9-70FF27FB65E0Q33954489-1C620A6A-0531-4E06-920C-638E177D160AQ33983596-AD853BE6-85DD-4F4B-971F-091663144CE2Q33997601-E6B793EA-FBD0-492E-A8EA-645BC8556E27Q33997638-F7F4DB69-7CD1-49A3-915D-64B403D8496EQ34038333-27360121-888B-46C6-92C1-C870AB40B505Q34058699-07A7167A-C437-4132-A667-FA409F44D873Q34126361-A35D0218-DD1C-4E61-AEB5-9C8CED6A78E3Q34218086-2668C0B6-E6EF-483B-9D67-0B3712B72530Q34245345-FC43AC05-71AE-48FB-B227-8A2F75379766Q34276940-2A85F8F4-FEE5-4B7E-B6B7-AFB5A4749D1EQ34484392-11D879EA-56F8-47EE-AC06-AB41F0F66F6BQ34556111-BBC75239-DD74-4155-A052-F0ED69E54A26Q34635114-1B3F5738-2B5B-4748-9312-C9FB5CFA9A5EQ34641729-8B3FDEDE-422F-4C87-8EFD-4E99875561C6
P2860
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
@ast
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
@en
type
label
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
@ast
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
@en
prefLabel
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
@ast
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
@en
P2093
P2860
P356
P1476
Glycogen synthase kinase-3beta is a negative regulator of cardiomyocyte hypertrophy
@en
P2093
A Alessandrini
A Rosenzweig
G Choukroun
J D Molkentin
P2860
P304
P356
10.1083/JCB.151.1.117
P407
P577
2000-10-01T00:00:00Z